• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,922.64 443.97
( 0.58%)
Global Indices
Nasdaq
52,316.93 113.19
(0.22%)
Dow Jones
7,516.83 55.40
(0.74%)
Hang Seng
70,577.01 514.69
(0.73%)
Nikkei 225
10,484.10 -13.02
(-0.12%)
Forex
USD-INR
94.49 0.37
(0.39%)
EUR-INR
107.78 0.64
(0.60%)
GBP-INR
125.01 0.85
(0.69%)
JPY-INR
0.58 0.00
(0.33%)

EQUITY - MARKET SCREENER

Sar Televenture Ltd
Industry :  Transmisson Line Towers / Equipment
BSE Code
ISIN Demat
Book Value()
91900
INE0PUC01020
165.6153348
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SARTELE
60.7
715.35
EPS(TTM)
Face Value()
Div & Yield %
2.35
2
0
 

Gennex Laboratories consolidated net profit rises 61.21% in the March 2026 quarter
Jun 01,2026
Net profit of Gennex Laboratories rose 61.21% to Rs 3.74 crore in the quarter ended March 2026 as against Rs 2.32 crore during the previous quarter ended March 2025. Sales rose 51.15% to Rs 60.96 crore in the quarter ended March 2026 as against Rs 40.33 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.52% to Rs 18.46 crore in the year ended March 2026 as against Rs 16.12 crore during the previous year ended March 2025. Sales rose 25.26% to Rs 172.74 crore in the year ended March 2026 as against Rs 137.90 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales60.9640.33 51 172.74137.90 25
OPM %9.655.01 -12.9819.69 -
PBDT6.134.65 32 26.4923.54 13
PBT4.974.10 21 23.8421.55 11
NP3.742.32 61 18.4616.12 15